{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T09:49:24Z","timestamp":1791539364284,"version":"4.3.4"},"reference-count":45,"publisher":"The Endocrine Society","issue":"11","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012264","name":"NIH","doi-asserted-by":"publisher","award":["OT2OD032644"],"award-info":[{"award-number":["OT2OD032644"]}],"id":[{"id":"10.13039\/501100012264","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,10,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Emerging data has identified a potential association between glucagon-like peptide-1 receptor agonists (GLP-1RAs) and nonarteritic anterior ischemic optic neuropathy (NAION), a typically sudden, painless, and irreversible cause of optic nerve-mediated vision loss. This review synthesizes the current clinical, epidemiologic, and potential mechanism linking GLP-1RA\u2013based therapies to NAION risk, informing balanced risk assessment and interdisciplinary clinical decision-making.<\/jats:p>\n                  <jats:p>A structured PubMed search was performed using terms including \u201cGLP-1 receptor agonist,\u201d \u201csemaglutide,\u201d \u201cliraglutide,\u201d \u201ctirzepatide,\u201d and \u201cnonarteritic anterior ischemic optic neuropathy,\u201d in addition to NAION risk factors, including disc-at-risk anatomy, type 2 diabetes, obstructive sleep apnea, hypertension, hyperlipidemia, renal disease, and ischemic heart disease.<\/jats:p>\n                  <jats:p>A small cup-to-disc ratio (\u201cdisc-at-risk\u201d) was found to be the most robust anatomical predictor of NAION. Systemic microvascular disease (diabetes, hypertension, hyperlipidemia) and conditions such as obstructive sleep apnea and end-stage renal disease were also linked to increased susceptibility to optic nerve head ischemia. Although data across electronic health records, national registries, and pharmacovigilance analyses suggest a very low absolute incidence of NAION, the use of GLP-1RAs demonstrates a statistically significant association with NAION development, yielding relative risk estimates between 1.2 and 4.3.<\/jats:p>\n                  <jats:p>At this time, the potential association between GLP-1RA therapy and NAION should be interpreted as a safety signal rather than a contraindication. Screening for disc-at-risk anatomy, consideration of prior NAION history, and patient counseling regarding acute visual symptoms may be warranted prior to initiation of therapy. As evidence evolves, collaboration between endocrinologists and ophthalmologists will be essential to support safe and effective patient care.<\/jats:p>","DOI":"10.1210\/jendso\/bvag224","type":"journal-article","created":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T12:03:20Z","timestamp":1790769800000},"source":"Crossref","is-referenced-by-count":0,"title":["Current review of glucagon-like peptide 1 receptor agonists and risk of nonarteritic anterior ischemic optic neuropathy"],"prefix":"10.1210","volume":"10","author":[{"given":"Franklin","family":"Ruan","sequence":"first","affiliation":[{"name":"Carle Illinois College of Medicine, University of Illinois Urbana-Champaign , Urbana, IL 61801, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhargavee","family":"Gnana","sequence":"additional","affiliation":[{"name":"Carle Illinois College of Medicine, University of Illinois Urbana-Champaign , Urbana, IL 61801, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cindy","family":"Mei","sequence":"additional","affiliation":[{"name":"Carle Illinois College of Medicine, University of Illinois Urbana-Champaign , Urbana, IL 61801, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Winnie","family":"Gong","sequence":"additional","affiliation":[{"name":"Carle Illinois College of Medicine, University of Illinois Urbana-Champaign , Urbana, IL 61801, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siddharth","family":"Limaye","sequence":"additional","affiliation":[{"name":"Carle Illinois College of Medicine, University of Illinois Urbana-Champaign , Urbana, IL 61801, USA"},{"name":"Shiley Eye Institute, UC San Diego Health , CA 92037, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Kim","sequence":"additional","affiliation":[{"name":"Carle Illinois College of Medicine, University of Illinois Urbana-Champaign , Urbana, IL 61801, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-0611-1596","authenticated-orcid":false,"given":"Erica A","family":"Person","sequence":"additional","affiliation":[{"name":"Carle Illinois College of Medicine, University of Illinois Urbana-Champaign , Urbana, IL 61801, USA"},{"name":"Department of Ophthalmology, Christie Clinic , Champaign, IL 61820, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2026,10,1]]},"reference":[{"key":"2026100904563186200_bvag224-B1","article-title":"GLP\u22121 receptor agonists for the treatment of obesity: role as a promising approach","volume":"14","author":"Wang","year":"2023","journal-title":"Front Endocrinol"},{"key":"2026100904563186200_bvag224-B2","volume-title":"StatPearls","author":"Collins","year":"2025"},{"issue":"20","key":"2026100904563186200_bvag224-B3","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1016\/j.jacc.2025.05.008","article-title":"2025 ACC scientific statement on the management of obesity in adults with heart failure: a report of the American College of Cardiology","volume":"86","author":"Kittleson","year":"2025","journal-title":"J Am Coll Cardiol"},{"issue":"24","key":"2026100904563186200_bvag224-B4","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1056\/NEJMoa2307563","article-title":"Semaglutide and cardiovascular outcomes in obesity without diabetes","volume":"389","author":"Lincoff","year":"2023","journal-title":"N Engl J Med"},{"issue":"2","key":"2026100904563186200_bvag224-B5","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1056\/NEJMoa2403347","article-title":"Effects of semaglutide on chronic kidney disease in patients with type 2 diabetes","volume":"391","author":"Perkovic","year":"2024","journal-title":"N Engl J Med"},{"issue":"5","key":"2026100904563186200_bvag224-B6","doi-asserted-by":"crossref","DOI":"10.1111\/obr.13709","article-title":"Highway to the danger zone? A cautionary account that GLP-1 receptor agonists may be too effective for unmonitored weight loss","volume":"25","author":"Richards","year":"2024","journal-title":"Obes Rev"},{"key":"2026100904563186200_bvag224-B7","doi-asserted-by":"crossref","DOI":"10.1016\/j.glmedi.2025.100183","article-title":"Online purchasing options for GLP-1 agonists: accessibility, marketing practices, and consumer safety concerns","volume":"5","author":"Basch","year":"2025","journal-title":"J Med Surg Public Health"},{"issue":"12","key":"2026100904563186200_bvag224-B8","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1038\/s41433-024-03136-8","article-title":"Review of evidence for treatments of acute non arteritic anterior ischemic optic neuropathy","volume":"38","author":"Parthasarathi","year":"2024","journal-title":"Eye (Lond)"},{"issue":"1","key":"2026100904563186200_bvag224-B9","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/eye.2014.144","article-title":"Current concepts in the diagnosis, pathogenesis and management of nonarteritic anterior ischaemic optic neuropathy","volume":"29","author":"Miller","year":"2015","journal-title":"Eye (Lond)"},{"key":"2026100904563186200_bvag224-B10","volume-title":"StatPearls","author":"Kaur","year":"2025"},{"key":"2026100904563186200_bvag224-B11","article-title":"Risk factors for non-arteritic anterior ischemic optic neuropathy: a large scale meta-analysis","volume":"8","author":"Liu","year":"2021","journal-title":"Front Med"},{"issue":"2","key":"2026100904563186200_bvag224-B12","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/BF00137137","article-title":"Anterior ischemic optic neuropathy: nonarteritic form in small and giant cell arteritis in normal sized optic discs","volume":"12","author":"Jonas","year":"1988","journal-title":"Int Ophthalmol"},{"issue":"8","key":"2026100904563186200_bvag224-B13","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1001\/jamaophthalmol.2024.2296","article-title":"Risk of nonarteritic anterior ischemic optic neuropathy in patients prescribed semaglutide","volume":"142","author":"Hathaway","year":"2024","journal-title":"JAMA Ophthalmol"},{"key":"2026100904563186200_bvag224-B14","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.ajo.2025.02.025","article-title":"The effect of semaglutide and GLP-1 RAs on risk of nonarteritic anterior ischemic optic neuropathy","volume":"274","author":"Abbass","year":"2025","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"2026100904563186200_bvag224-B15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0247126","article-title":"Risk factors and visual outcome of Non-Arteritic Ischemic Optic Neuropathy (NAION): experience of a tertiary center in Kuwait","volume":"16","author":"Behbehani","year":"2021","journal-title":"PLoS One"},{"issue":"7","key":"2026100904563186200_bvag224-B16","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.ophtha.2024.01.011","article-title":"Ophthalmic and systemic factors of acute nonarteritic anterior ischemic optic neuropathy in the Quark207 treatment trial","volume":"131","author":"Kupersmith","year":"2024","journal-title":"Ophthalmology"},{"issue":"4","key":"2026100904563186200_bvag224-B17","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.ophtha.2016.11.029","article-title":"Comparison of visual outcomes of nonarteritic anterior ischemic optic neuropathy in patients with and without diabetes mellitus","volume":"124","author":"Sharma","year":"2017","journal-title":"Ophthalmology"},{"issue":"5","key":"2026100904563186200_bvag224-B18","doi-asserted-by":"crossref","first-page":"869","DOI":"10.18240\/ijo.2024.05.11","article-title":"Risk factors of non-arteritic anterior ischaemic optic neuropathy and central retinal artery occlusion","volume":"17","author":"Ma","year":"2024","journal-title":"Int J Ophthalmol"},{"issue":"3","key":"2026100904563186200_bvag224-B19","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1080\/08820538.2019.1620792","article-title":"Disc configuration as a risk and prognostic factor in NAION: the impact of cup to disc ratio, disc diameter, and crowding index","volume":"34","author":"Gonz\u00e1lez Mart\u00edn-Moro","year":"2019","journal-title":"Semin Ophthalmol"},{"key":"2026100904563186200_bvag224-B20","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.ajo.2022.06.016","article-title":"Optic nerve head anatomy and vascular risk factors in patients with optic disc drusen associated anterior ischemic optic neuropathy","volume":"242","author":"Johannesen","year":"2022","journal-title":"Am J Ophthalmol"},{"key":"2026100904563186200_bvag224-B21","doi-asserted-by":"crossref","DOI":"10.3389\/fopht.2025.1554279","article-title":"Low anterior chamber volume as a risk factor in non-arteritic anterior ischemic optic neuropathy","volume":"5","author":"Acan","year":"2025","journal-title":"Front Ophthalmol"},{"issue":"9","key":"2026100904563186200_bvag224-B22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0076653","article-title":"The association between diabetes mellitus and nonarteritic anterior ischemic optic neuropathy: a systematic review and meta-analysis","volume":"8","author":"Chen","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"2026100904563186200_bvag224-B23","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1159\/000528627","article-title":"Risk factors for fellow eye involvement in patients with nonarteritic anterior ischemic optic neuropathy","volume":"66","author":"Li","year":"2023","journal-title":"Ophthalmic Res"},{"issue":"5","key":"2026100904563186200_bvag224-B24","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1034\/j.1600-0420.2002.800503.x","article-title":"Ocular perfusion abnormalities in diabetes","volume":"80","author":"Ciulla","year":"2002","journal-title":"Acta Ophthalmol Scand"},{"issue":"10","key":"2026100904563186200_bvag224-B25","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.oftal.2024.04.009","article-title":"Non-arteritic anterior ischemic optic neuropathy as the only manifestation of a malignant hypertensive crisis: report of a case","volume":"99","author":"Miralles Pechuan","year":"2024","journal-title":"Arch Soc Esp Oftalmol (Engl Ed)"},{"issue":"5","key":"2026100904563186200_bvag224-B26","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/S0161-6420(03)00079-4","article-title":"Ischemic optic neuropathy as the first manifestation of elevated cholesterol levels in young patients","volume":"110","author":"Deramo","year":"2003","journal-title":"Ophthalmology"},{"issue":"7","key":"2026100904563186200_bvag224-B27","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1001\/jamaophthalmol.2015.0893","article-title":"Association of nonarteritic ischemic optic neuropathy with obstructive sleep apnea syndrome: consequences for obstructive sleep apnea screening and treatment","volume":"133","author":"Aptel","year":"2015","journal-title":"JAMA Ophthalmol"},{"issue":"6","key":"2026100904563186200_bvag224-B28","doi-asserted-by":"crossref","first-page":"613","DOI":"10.5664\/jcsm.2766","article-title":"Obstructive sleep apnea and nonarteritic anterior ischemic optic neuropathy: evidence for an association","volume":"9","author":"Archer","year":"2013","journal-title":"J Clin Sleep Med"},{"issue":"3","key":"2026100904563186200_bvag224-B29","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1080\/01658107.2024.2443194","article-title":"The characteristics and visual outcomes of dialysis-associated non-arteritic ischemic optic neuropathy: a comprehensive systematic review","volume":"49","author":"Abu Serhan","year":"2025","journal-title":"Neuroophthalmology"},{"issue":"12","key":"2026100904563186200_bvag224-B30","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000003174","article-title":"Risk of nonarteritic anterior ischemic optic neuropathy following end-stage renal disease","volume":"95","author":"Chang","year":"2016","journal-title":"Medicine (Baltimore)"},{"issue":"4","key":"2026100904563186200_bvag224-B31","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1001\/jamaophthalmol.2024.6555","article-title":"Semaglutide and nonarteritic anterior ischemic optic neuropathy","volume":"143","author":"Cai","year":"2025","journal-title":"JAMA Ophthalmol"},{"issue":"2","key":"2026100904563186200_bvag224-B32","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1111\/dom.70200","article-title":"GLP-1RA and the risk of non-arteritic anterior ischaemic optic neuropathy in patients with type 2 diabetes: a population-based study","volume":"28","author":"Tesfaye","year":"2026","journal-title":"Diabetes Obes Metab"},{"issue":"1","key":"2026100904563186200_bvag224-B33","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.orcp.2025.01.011","article-title":"Semaglutide: nonarteritic anterior ischemic optic neuropathy in the FDA adverse event reporting system\u2014a disproportionality analysis","volume":"19","author":"Azab","year":"2025","journal-title":"Obes Res Clin Pract"},{"issue":"8","key":"2026100904563186200_bvag224-B34","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2025.26327","article-title":"Semaglutide or tirzepatide and optic nerve and visual pathway disorders in type 2 diabetes","volume":"8","author":"Wang","year":"2025","journal-title":"JAMA Netw Open"},{"issue":"2","key":"2026100904563186200_bvag224-B35","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1111\/dom.16076","article-title":"Glucagon-like peptide 1 (GLP1) receptor agonists and risk for ischemic optic neuropathy: a meta-analysis of randomised controlled trials","volume":"27","author":"Silverii","year":"2025","journal-title":"Diabetes Obes Metab"},{"key":"2026100904563186200_bvag224-B36","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2023-076410","article-title":"Comparative effectiveness of GLP-1 receptor agonists on glycaemic control, body weight, and lipid profile for type 2 diabetes: systematic review and network meta-analysis","volume":"384","author":"Yao","year":"2024","journal-title":"BMJ"},{"issue":"1","key":"2026100904563186200_bvag224-B37","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s12902-017-0213-3","article-title":"Mechanism of worsening diabetic retinopathy with rapid lowering of blood glucose: the synergistic hypothesis","volume":"17","author":"Jingi","year":"2017","journal-title":"BMC Endocr Disord"},{"issue":"11","key":"2026100904563186200_bvag224-B38","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1001\/archopht.126.11.1582","article-title":"Hypothesis: a venous etiology for nonarteritic anterior ischemic optic neuropathy","volume":"126","author":"Levin","year":"2008","journal-title":"Arch Ophthalmol"},{"issue":"4","key":"2026100904563186200_bvag224-B39","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1167\/iovs.09-3492","article-title":"Optic disc morphology in open-angle glaucoma compared with anterior ischemic optic neuropathies","volume":"51","author":"Danesh-Meyer","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"11","key":"2026100904563186200_bvag224-B40","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1016\/j.ophtha.2010.03.006","article-title":"Bilateral diabetic papillopathy and metabolic control","volume":"117","author":"Ostri","year":"2010","journal-title":"Ophthalmology"},{"issue":"3","key":"2026100904563186200_bvag224-B41","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1001\/jamaophthalmol.2024.6058","article-title":"Ophthalmic complications associated with the antidiabetic drugs semaglutide and tirzepatide","volume":"143","author":"Katz","year":"2025","journal-title":"JAMA Ophthalmol"},{"key":"2026100904563186200_bvag224-B42","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.preteyeres.2015.10.001","article-title":"Pathogenesis of optic disc edema in raised intracranial pressure","volume":"50","author":"Hayreh","year":"2016","journal-title":"Prog Retin Eye Res"},{"issue":"6","key":"2026100904563186200_bvag224-B43","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1001\/archopht.118.6.793","article-title":"Ischemic optic neuropathy decompression trial: twenty-four\u2013month update","volume":"118","author":"Ischemic Optic Neuropathy Decompression Trial Research Group","year":"2000","journal-title":"Arch Ophthalmol"},{"key":"2026100904563186200_bvag224-B44","author":"American Academy of Ophthalmology Board of Trustees and the North American Neuro-Ophthalmology Society","year":"2026"},{"key":"2026100904563186200_bvag224-B45","author":"American Optometric Association"}],"container-title":["Journal of the Endocrine Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jes\/advance-article-pdf\/doi\/10.1210\/jendso\/bvag224\/71532782\/bvag224.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jes\/article-pdf\/10\/11\/bvag224\/71532782\/bvag224.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jes\/article-pdf\/10\/11\/bvag224\/71532782\/bvag224.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T08:56:44Z","timestamp":1791536204000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jes\/article\/doi\/10.1210\/jendso\/bvag224\/8855774"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,1]]},"references-count":45,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,10,5]]}},"URL":"https:\/\/doi.org\/10.1210\/jendso\/bvag224","relation":{},"ISSN":["2472-1972"],"issn-type":[{"value":"2472-1972","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,11]]},"published":{"date-parts":[[2026,10,1]]},"article-number":"bvag224"}}